slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 12,121-12,150
Pages 3,225
Rows per page 30
Component
12,121-12,150 of 96,741
59
The chart highlights the year-end price of $130.Pershing Square Portfolio (multi-position annual update) · Pershing Square Capital Management
Activist deck Activist investor Beat · Action2 hits
60
The slide highlights a significant positive return following a corporate spinoff.Pershing Square Portfolio (multi-position annual update) · Pershing Square Capital Management
Activist deck Activist investor Beat · Action2 hits
63
The chart highlights a specific event (court dismissal) that correlates with a sharp drop in share price.Pershing Square Portfolio (multi-position annual update) · Pershing Square Capital Management
Activist deck Activist investor Beat · Action2 hits
68
The chart uses a callout to mark the acquisition event.Pershing Square Portfolio (multi-position annual update) · Pershing Square Capital Management
Activist deck Activist investor Beat · Action2 hits
06
The chart highlights a significant performance outperformance of Pershing Square (722.9%) versus the S&P 500 (134.3%).Pershing Square Portfolio (multiple positions) · Pershing Square
Activist deck Activist investor Beat · Humble Origins2 hits
16
Uses red callout box for the primary thesis and red 'X' icons for the supporting arguments.Pershing Square Portfolio (multiple positions) · Pershing Square
Activist deck Activist investor Beat · Early StrugglesLoop · Before After2 hits
24
The slide uses a timeline-annotated line chart to demonstrate value creation following activist intervention.Pershing Square Portfolio (multiple positions) · Pershing Square
Activist deck Activist investor Beat · Rising SuccessLoop · Before After2 hits
51
The slide uses a red box to highlight North America and Mexico as the primary drivers of the decline.Pershing Square Portfolio (multiple positions) · Pershing Square
Activist deck Activist investor Beat · Ultimate Achievement2 hits
05
This slide appears to be from an activist presentation (likely Pershing Square's Herbalife deck) used to establish the company's expansion history.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Call2 hits
07
The slide uses a table to demonstrate the increasing reliance on the Chinese market.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Monster2 hits
10
The slide uses a yellow background callout box to emphasize the legal constraints.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The MonsterLoop · Analogy2 hits
16
The slide uses a yellow callout box to emphasize the lack of consumer value in the Preferred Customer program.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Monster2 hits
17
The slide uses a quote from a 2013 news article to frame the business model as a disguised form of recruitment fees.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Monster2 hits
18
This slide is likely from an activist presentation (Pershing Square/Ackman) critiquing Herbalife's business model by highlighting how 'credits' are framed as 'salary'.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Monster2 hits
19
The slide highlights the structural incentive for recruiting inherent in the compensation model.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Monster2 hits
20
The slide uses a green box to highlight the recruitment requirement and a yellow box to emphasize the incentive structure, framing it as a critique of the business model.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Monster2 hits
22
The slide uses a table to expose the predatory nature of a multi-level marketing structure by comparing high entry costs to national GDP.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Struggle2 hits
23
The slide uses a green callout box to emphasize the deceptive nature of the compensation terminology.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Struggle2 hits
27
The slide uses a direct quote to expose the mechanics of a multi-level marketing structure, specifically highlighting the distributor's own awareness of the 'pyramid' perception.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Struggle2 hits
29
Herbalife, Ltd. (HLF)Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Struggle2 hits
37
Uses a simple causal flow diagram to link a business practice to legal violation.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Struggle2 hits
38
Herbalife, Ltd. (HLF)Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Struggle2 hits
39
Uses a simple causal flow diagram to show the violation of a specific legal article.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Struggle2 hits
40
Uses a visual arrow to connect business practices to legal definitions.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Struggle2 hits
09
Uses a diagnostic structure to debunk potential explanations for stock performance.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor Beat · Problem2 hits
12
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor Loop · Logic Chain2 hits
17
The slide outlines the core pillars of Valeant's M&A success.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor Loop · Logic Chain2 hits
23
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor Beat · Agitate2 hits
31
Includes disclaimer regarding valuation assumptions and data sources.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 2 hits
40
The slide justifies using non-healthcare benchmarks for valuation by highlighting similar margin and growth profiles.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 2 hits